{"id":56058,"date":"2023-04-20T17:06:21","date_gmt":"2023-04-20T15:06:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/"},"modified":"2023-04-20T17:06:21","modified_gmt":"2023-04-20T15:06:21","slug":"vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/","title":{"rendered":"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b><i>Study led by an academic-industry collaboration proves viability to remotely recruit and engage participants for ongoing data collection in infectious disease research<\/i><\/b><\/p>\n<p>FAIRFAX, Va.&#8211;(BUSINESS WIRE)&#8211;Vibrent Health, a leading software-as-a-service company in the field of precision health research, announced today the publication of a methods paper in JMIR Formative Research (JFR). The prospective cohort study is titled <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fformative.jmir.org%2F2023%2F1%2Fe37550%23ref17&amp;esheet=53384635&amp;newsitemid=20230420005564&amp;lan=en-US&amp;anchor=A+Digital+Health+Initiative+%28COVIDsmart%29+for+Remote+Data+Collection+and+Study+of+COVID-19%26%238217%3Bs+Impact+on+the+State+of+Virginia&amp;index=1&amp;md5=9bab032480d1edc58ec38b002c19c806\" rel=\"nofollow noopener\" shape=\"rect\">A Digital Health Initiative (COVIDsmart) for Remote Data Collection and Study of COVID-19\u2019s Impact on the State of Virginia<\/a>.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/4\/VibrentLogo_C_S_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg\"><\/a><\/p>\n<p>\nThe peer-reviewed study aims to determine individuals&#8217; social, mental, and physical well-being across the state of Virginia, an area with evidence of a growing rural-urban demographic divide. Increasingly, there are distinct socioeconomic differences between the multiethnic population of Northern Virginia and the predominately white population in rural communities. This unique sociodemographic distribution offers an interesting and important source to examine the multifaceted impact of the COVID-19 pandemic in a broad range of lifestyle, environmental, economic, and social settings.<\/p>\n<p>\nThe study is led by an industry-academic collaboration including <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vibrenthealth.com%2Fproducts&amp;esheet=53384635&amp;newsitemid=20230420005564&amp;lan=en-US&amp;anchor=Vibrent+Health&amp;index=2&amp;md5=cab0acad1f00e5f37673e8908381b437\" rel=\"nofollow noopener\" shape=\"rect\">Vibrent Health<\/a>, George Mason University, and the Healthcare Analytics and Delivery Science Institute (HADSI)\u2014a collaboration between Eastern Virginia Medical School and regional healthcare provider Sentara. A study team comprised of experts from these organizations collaboratively designed and deployed a statewide digital health research study called COVIDsmart to understand the effects of COVID-19<\/p>\n<p>\nCOVIDsmart relies exclusively on digital methods for eConsent, participant communication and engagement, and data collection. The study team used the scientifically-validated ResearchCloud Enterprise platform across multiple research domains, including physiological, neurological, social neuroscience, socio-psychological, and behavioral economics.<\/p>\n<p>\nAt time of publication of the paper, the study was able to convert nearly 21% of visitors to the study website, using only digital touchpoints. The most successful recruitment modality resulting in study enrollment was the use of newsletters or emails that popularized the study across the target catchment areas within Virginia.<\/p>\n<p>\n\u201cThe preliminary findings of COVIDsmart demonstrate that individuals are willing to participate in fully-remote digital health research, which is promising news for infectious disease research,\u201d said Vibrent Health CEO Praduman \u201cPJ\u201d Jain. \u201cDigital methods not only enable researchers to scale their participant populations over larger areas, but also protect patients and research teams from potential risks of in-person data collection. The high level of engagement in this study confirms the viability of this approach.\u201d<\/p>\n<p>\nThe data collected remotely included mood, social communication and isolation, alcohol dependency, sleep deprivation, and other behavioral risk indicators over time. The study team also implemented incentives, reminders, and other retention strategies for participants.<\/p>\n<p>\nThis concluded study represents a growing priority within the research community to build permanence and sustainability in infectious disease research. Digital health research using platforms like <b>Research<\/b>Cloud Enterprise provide a safe, scalable, and speedy model for infectious disease and epidemic monitoring.<\/p>\n<p>\n\u201cThe industry-academic collaboration for COVIDsmart holds great promise for accelerating research in infectious disease, and we hope to do more of it,\u201d said Jain. \u201cWe are actively working to support more collaborations and invite other research programs to partner with us in these initiatives to accelerate the benefit to global health.\u201d<\/p>\n<p>\nTo discuss potential collaborations in health or clinical research, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.vibrenthealth.com%2Frequest-a-pilot&amp;esheet=53384635&amp;newsitemid=20230420005564&amp;lan=en-US&amp;anchor=https%3A%2F%2Finfo.vibrenthealth.com%2Frequest-a-pilot&amp;index=3&amp;md5=1254e697eb931922ef0a2303fafbfb21\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/info.vibrenthealth.com\/request-a-pilot<\/a>.<\/p>\n<p>\n<b>About Vibrent Health<\/b><\/p>\n<p>\nVibrent Health develops digital health technology and research tools for health organizations, researchers and research participants. Powering the next generation of precision medicine, Vibrent\u2019s scalable technology platform for individual and population health provides actionable insights to help accelerate medical discoveries. Vibrent Health is proud to serve, since 2017, as the Participant Technology Systems Center for the National Institutes of Health\u2019s <i>All of Us<\/i> Research Program, which aims to collect health data from 1 million or more people to support a wide variety of research studies. Since 2020, Vibrent has also collaborated with numerous organizations to conduct a variety of research initiatives spanning several topics, including precision medicine, cancer, COVID, substance abuse, aging, and fertility, among others. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vibrenthealth.com%2F&amp;esheet=53384635&amp;newsitemid=20230420005564&amp;lan=en-US&amp;anchor=vibrenthealth.com&amp;index=4&amp;md5=d8f16987368c50beb996fa86680bbfb2\" rel=\"nofollow noopener\" shape=\"rect\">vibrenthealth.com<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMolly Bryant<br \/>\n<br \/>Vice President<br \/>\n<br \/>Email &#8211; <a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;m&#x62;&#x72;&#121;an&#x74;&#64;&#118;i&#x62;&#x72;&#101;n&#x74;&#x68;&#101;&#97;l&#x74;&#x68;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x62;&#x72;&#x79;&#97;&#110;t&#64;v&#x69;&#x62;&#x72;&#x65;&#110;&#116;hea&#x6c;&#x74;&#x68;&#x2e;&#99;&#111;&#109;<\/a><br \/>Phone &#8211; 843.814.8623<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Study led by an academic-industry collaboration proves viability to remotely recruit and engage participants for ongoing data collection in infectious disease research FAIRFAX, Va.&#8211;(BUSINESS WIRE)&#8211;Vibrent Health, a leading software-as-a-service company in the field of precision health research, announced today the publication of a methods paper in JMIR Formative Research (JFR). The prospective cohort study is &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56058","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Study led by an academic-industry collaboration proves viability to remotely recruit and engage participants for ongoing data collection in infectious disease research FAIRFAX, Va.&#8211;(BUSINESS WIRE)&#8211;Vibrent Health, a leading software-as-a-service company in the field of precision health research, announced today the publication of a methods paper in JMIR Formative Research (JFR). The prospective cohort study is ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T15:06:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact\",\"datePublished\":\"2023-04-20T15:06:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/\"},\"wordCount\":683,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005564\\\/en\\\/816694\\\/21\\\/VibrentLogo_C_S_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/\",\"name\":\"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005564\\\/en\\\/816694\\\/21\\\/VibrentLogo_C_S_RGB.jpg\",\"datePublished\":\"2023-04-20T15:06:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005564\\\/en\\\/816694\\\/21\\\/VibrentLogo_C_S_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005564\\\/en\\\/816694\\\/21\\\/VibrentLogo_C_S_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/","og_locale":"en_US","og_type":"article","og_title":"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact - Pharma Trend","og_description":"Study led by an academic-industry collaboration proves viability to remotely recruit and engage participants for ongoing data collection in infectious disease research FAIRFAX, Va.&#8211;(BUSINESS WIRE)&#8211;Vibrent Health, a leading software-as-a-service company in the field of precision health research, announced today the publication of a methods paper in JMIR Formative Research (JFR). The prospective cohort study is ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-20T15:06:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact","datePublished":"2023-04-20T15:06:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/"},"wordCount":683,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/","url":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/","name":"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg","datePublished":"2023-04-20T15:06:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230420005564\/en\/816694\/21\/VibrentLogo_C_S_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vibrent-health-announces-publication-of-a-peer-reviewed-scientific-paper-for-a-study-using-exclusively-digital-methods-for-data-collection-to-study-covid-19s-impact\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19\u2019s Impact"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56058"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56058\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}